Bruton's tyrosine kinase is required for apoptotic cell uptake via regulating the phosphorylation and localization of calreticulin

Journal of Immunology

Volumn 190, Issue 10, 2013, Pages 5207-5215

  Byrne, Jennifer C ^a   Gabhann, Joan Ni ^a   Stacey, Kevin B ^a   Coffey, Barbara M ^a   McCarthy, Eoghan ^a   Thomas, Warren ^b   Jefferies, Caroline A ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CALRETICULIN; CALRETICULIN ANTIBODY; COMPLEMENT COMPONENT C1Q; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEIN ANTIBODY; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOREGULATION; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

ANIMALS; ANTIBODIES, BLOCKING; APOPTOSIS; CALRETICULIN; CELL LINE; CELL MEMBRANE; COMPLEMENT C1Q; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MYELOID CELLS; PHAGOCYTOSIS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, LDL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; TUMOR SUPPRESSOR PROTEINS;

EID: 84877830625     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300057     Document Type: Article

References (42)

1. Rahman, Z. S. 2011. Impaired clearance of apoptotic cells in germinal centers: implications for loss of B cell tolerance and induction of autoimmunity. Immunol. Res. 51: 125-133.
2. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
3. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975. (Pubitemid 37323217)
4. Sim, R. B., S. K. Moestrup, G. R. Stuart, N. J. Lynch, J. Lu,W. J. Schwaeble, and R. Malhotra. 1998. Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin. Immunobiology 199: 208-224. (Pubitemid 28404343)
5. Jefferies, C. A., and L. A. J. O'Neill. 2004. Bruton's tyrosine kinase (Btk)-the critical tyrosine kinase in LPS signalling? Immunol. Lett. 92: 15-22. (Pubitemid 38470045)
6. Jefferies, C. A., S. Doyle, C. Brunner, A. Dunne, E. Brint, C. Wietek, E. Walch, T. Wirth, and L. A. J. O'Neill. 2003. Bruton's tyrosine kinase is a Toll/ interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J. Biol. Chem. 278: 26258-26264. (Pubitemid 36835395)
7. Doyle, S. L., C. A. Jefferies, and L. A. O'Neill. 2005. Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide. J. Biol. Chem. 280: 23496-23501. (Pubitemid 40884827)
8. Doyle, S. L., C. A. Jefferies, C. Feighery, and L. A. J. O'Neill. 2007. Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. J. Biol. Chem. 282: 36953-36960.
9. Lee, K.-G., S. Xu, Z.-H. Kang, J. Huo, M. Huang, D. Liu, O. Takeuchi, S. Akira, and K.-P. Lam. 2012. Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response. Proc. Natl. Acad. Sci. USA 109: 5791-5796.
10. Ní Gabhann, J., S. Spence, C. Wynne, S. Smith, J. C. Byrne, B. Coffey, K. Stacey, A. Kissenpfennig, J. Johnston, and C. A. Jefferies. 2012. Defects in acute responses to TLR4 in Btk-deficient mice result in impaired dendritic cellinduced IFN-g production by natural killer cells. Clin. Immunol. 142: 373-382.
11. Vijayan, V., E. Baumgart-Vogt, S. Naidu, G. Qian, and S. Immenschuh. 2011. Bruton's tyrosine kinase is required for TLR-dependent heme oxygenase-1 gene activation via Nrf2 in macrophages. J. Immunol. 187: 817-827.
12. Liu, X., Z. Zhan, D. Li, L. Xu, F. Ma, P. Zhang, H. Yao, and X. Cao. 2011. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat. Immunol. 12: 416-424.
13. Amoras, A. L. B., H. Kanegane, T. Miyawaki, and M. M. S. Vilela. 2003. Defective Fc-, CR1-And CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. J. Investig. Allergol. Clin. Immunol. 13: 181-188. (Pubitemid 37408722)
14. Yoshino, A., M. Honda, H. Kanegane, K. Obata, H. Matsukura, S. Sakazume, Y. Katada, T. Miyawaki, Y. Ueda, and T. Nagai. 2006. Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia. Pediatr. Nephrol. 21: 36-38. (Pubitemid 43040192)
15. Endo, L. M., J. V. Giannobile, A. K. Dobbs, J. B. Foote, E. Szymanska, D. G. Warnock, W. J. Cook, M. E. Conley, and H. W. Schroeder. 2011. Mem-branous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin. J. Investig. Allergol. Clin. Immunol. 21: 405-409.
16. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672. (Pubitemid 43902669)
17. Subramanian, S., K. Tus, Q.-Z. Li, A. Wang, X.-H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103: 9970-9975. (Pubitemid 43993607)
18. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428. (Pubitemid 44354217)
19. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-Associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177. (Pubitemid 41586947)
20. Weck, M. M., F. Grunebach, D. Werth, C. Sinzger, A. Bringmann, and P. Brossart. 2007. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109: 3890-3894. (Pubitemid 46641741)
21. Hendriks, R. W., M. F. de Bruijn, A. Maas, G. M. Dingjan, A. Karis, and F. Grosveld. 1996. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15: 4862-4872. (Pubitemid 26315797)
22. Byrne, J. C., M. R. Downes, N. O'Donoghue, C. O'Keane, A. O'Neill, Y. Fan, J. M. Fitzpatrick, M. Dunn, and R.W.Watson. 2009. 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer. J. Proteome Res. 8: 942-957.
23. Ogden, C. A., A. deCathelineau, P. R. Hoffmann, D. Bratton, B. Ghebrehiwet, V. A. Fadok, and P. M. Henson. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194: 781-795. (Pubitemid 32983014)
24. Jongstra-Bilen, J., A. Puig Cano, M. Hasija, H. Xiao, C. I. E. Smith, and M. I. Cybulsky. 2008. Dual functions of Bruton's tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis. J. Immunol. 181: 288-298.
25. Vandivier, R. W., C. A. Ogden, V. A. Fadok, P. R. Hoffmann, K. K. Brown, M. Botto, M. J. Walport, J. H. Fisher, P. M. Henson, and K. E. Greene. 2002. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169: 3978-3986.
26. Gardai, S. J., K. A. McPhillips, S. C. Frasch, W. J. Janssen, A. Starefeldt, J. E. Murphy-Ullrich, D. L. Bratton, P.-A. Oldenborg, M. Michalak, and P. M. Henson. 2005. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-Activation of LRP on the phagocyte. Cell 123: 321-334. (Pubitemid 41457220)
27. Cristina Castaneda-Patlán, M., R. Razo-Paredes, R. Carrisoza-Gaytán, L. González-Mariscal, and M. Robles-Flores. 2010. Protein kinase C is involved in the regulation of several calreticulin posttranslational modifications. Int J Biochem Cell Biol 42: 120-131.
28. Husebye, H., M. H. Aune, J. Stenvik, E. Samstad, F. Skjeldal, O. Halaas, N. J. Nilsen, H. Stenmark, E. Latz, E. Lien, et al. 2010. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33: 583-596.
29. Herrmann, M., R. E. Voll, O. M. Zoller, M. Hagenhofer, B. B. Ponner, and J. R. Kalden. 1998. Impaired phagocytosis of apoptotic cell material by monocytederived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41: 1241-1250. (Pubitemid 28313427)
30. Donnelly, S., W. Roake, S. Brown, P. Young, H. Naik, P. Wordsworth, D. A. Isenberg, K. B. M. Reid, and P. Eggleton. 2006. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 54: 1543-1556.
31. Horwood, N. J., T. Mahon, J. P. McDaid, J. Campbell, H. Mano, F. M. Brennan, D. Webster, and B. M. J. Foxwell. 2003. Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor a production. J. Exp. Med. 197: 1603-1611. (Pubitemid 36745336)
32. Horwood, N. J., T. H. Page, J. P. McDaid, C. D. Palmer, J. Campbell, T. Mahon, F. M. Brennan, D. Webster, and B. M. J. Foxwell. 2006. Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J. Immunol. 176: 3635-3641. (Pubitemid 43364011)
33. Pérez de Diego, R., E. López-Granados, M. Pozo, C. Rodríguez, P. Sabina, A. Ferreira, G. Fontan, M. C. García- Rodríguez, and S. Alemany. 2006. Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. J. Allergy Clin. Immunol. 117: 1462-1469. (Pubitemid 44208984)
34. Marron, T. U., M. Martinez-Gallo, J. E. Yu, and C. Cunningham-Rundles. 2012. Toll-like receptor 4-, 7-, and 8-Activated myeloid cells from patients with Xlinked agammaglobulinemia produce enhanced inflammatory cytokines. J. Allergy Clin. Immunol. 129: 184-190.e1-e4.
35. Mueller, C. F. H., K. Wassmann, A. Berger, S. Holz, S. Wassmann, and G. Nickenig. 2008. Differential phosphorylation of calreticulin affects AT1 receptor mRNA stability in VSMC. Biochem. Biophys. Res. Commun. 370: 669-674.
36. Singh, N. K., C. D. Atreya, and H. L. Nakhasi. 1994. Identification of calreticulin as a rubella virus RNA binding protein. Proc. Natl. Acad. Sci. USA 91: 12770-12774.
37. Kagan, J. C., T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. [beta] Nat. Immunol. 9: 361-368. (Pubitemid 351405105)
38. Honoré, C., T. Hummelshoj, B. E. Hansen, H. O. Madsen, P. Eggleton, and P. Garred. 2007. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum. 56: 1598-1607. (Pubitemid 46764089)
39. Muller-Taubenberger, A., A. N. Lupas, H. Li, M. Ecke, E. Simmeth, and G. Gerisch. 2001. Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J. 20: 6772-6782. (Pubitemid 33134207)
40. Garin, J., R. Diez, S. Kieffer, J.-F. Dermine, S. Duclos, E. Gagnon, R. Sadoul, C. Rondeau, and M. Desjardins. 2001. The phagosome proteome: insight into phagosome functions. J. Cell Biol. 152: 165-180. (Pubitemid 32102445)
41. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59. (Pubitemid 28242023)
42. Walport, M. J., K. A. Davies, and M. Botto. 1998. C1q and systemic lupus erythematosus. Immunobiology 199: 265-285. (Pubitemid 28404347)